Hemolytic anemia triggered by the consumption of faba beans in a patient with glucose-6-phosphate dehydrogenase deficiency: a pediatric case report
https://orcid.org/0000-0002-3981-2650
Holman Leonel Franco
https://orcid.org/0000-0002-4000-6533
Adriana Marcela Pulido Buitrago
https://orcid.org/0000-0002-9462-5196
Erika Johanna Gómez León
https://orcid.org/0000-0002-4322-8043
Sebastian Saldaña Franco
https://orcid.org/0000-0001-7233-1413
##plugins.themes.bootstrap3.article.details##
Glucose 6 phosphate dehydrogenase deficiency (G6PD) is the most common metabolic disorder of red blood cells, being hemolytic anemia its most frequent presentation which can be triggered by infectious processes, medications or the ingestion of fava beans; the latter called Favism. Objective: To describe the clinical presentation of G6PD deficiency in a child after consumption of fava beans. Clinical case: 3 year old male, who presents with generalized jaundice associated with choluria, consumption of fava beans prior to the onset of symptoms, favism is suspected. Moderate anemia, indirect bilirubin increase, elevation of lactate, peripheral blood smears with spherocytes, and polychromatophilia were documented. Management with folic acid was initiated. A measurement of G6PD enzyme was performed and a moderate (class III) deficiency was confirmed. Conclusion: G6PD deficiency is a diagnostic challenge. With proper management and prevention, cases with severe hemolysis can be avoided. It is important to introduce G6PD analysis in neonatal screening in order to achieve a decrease in infant morbidity and mortality.
reporte de caso, favismo, deficiencia de glucosa 6 fosfato deshidrogenasa, anemia hemolítica, ictericiacase reports, favism, glucose 6 phosphate dehydrogenase deficiency, hemolytic anemia, jaundice
1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74.
2. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-78. https://doi.org/10.1016/j.bcmd.2008.12.005
3. Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Phys. 2005;72(7):1277-82.
4. Adam A. Linkage between deficiency of glucose-6-phosphate dehydrogenase and colour-blindness. Nature. 1961;189(4765):686.
5. Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, et al. Structural analysis of the X‐linked gene encoding human glucose 6‐phosphate dehydrogenase. EMBO J. 1986;5(8):1849-55. https://doi.org/10.1002/j.1460-2075.1986.tb04436.x
6. Spring R, Schlaack H, Rice M, Staat MA, Quinn CT. Glucose‐6‐phosphate dehydrogenase deficiency in internationally adopted children. Pediatr Blood Cancer. 2018;65(5):e26990. https://doi.org/10.1002/pbc.26990
7. Van Zwieten R, Verhoeven AJ, Roos D. Inborn defects in the antioxidant systems of human red blood cells. Free Rad Biol Med. 2014;67:377-86. https://doi.org/10.1016/j.freeradbiomed.2013.11.022
8. Beutler E. The molecular biology of G6PD variants and other red cell enzyme defects. Ann Rev Med. 1992;43(1):47-59. https://doi.org/10.1146/annurev.me.43.020192.000403
9. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. WHO Bulletin OMS. 1989;67:601-11.
10. Uribe A. Deficiencia de glucosa 6-fosfato deshidrogenasa en Colombia: memorias de 22 años de tamizaje de alto riesgo. Revista Med. 2017;25(2):7-21.
11. Belfield KD, Tichy EM. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency. Am J Health Syst Pharm. 2018;75(3):97-104. https://doi.org/10.2146/ajhp160961
12. Ramírez-Cheyne J, Zarante I. Deficiencia de glucosa-6-fosfato deshidrogenasa: situación actual, su relación con malaria y estrategias para calcular su prevalencia. Univ Méd. 2009;50(1):58-76.
13. Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC. Glucose-6-phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia: insights on pathophysiology, diagnosis, and gene variants in disease heterogeneity. Front Pediatr. 2022;10:875877. https://doi.org/10.3389/fped.2022.875877
14. Beutler E. G6PD deficiency. Blood. 1994;84(11):3613-36.
15. Luzzatto L, Arese P. Favism and glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 2018;378(1):60-71. https://doi.org/10.1056/nejmra1708111
16. Villegas JB. La ley de tamizaje neonatal en Colombia. Medicina. 2019;41(4):297-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.